By week 28, it reached about 10%
Topical patches have different risk considerations than oral or injected medications
Patients with a personal history of medullary thyroid carcinoma (MTC) should discuss this with their specialist before considering GLP-1 medications
Weng Z, Zhang B, Asadi S, Sismanopoulos N, Butcher A, Fu X, Katsarou-Katsari A, Antoniou C, Theoharides TC
As mentioned earlier, these patches, which contain natural ingredients 3 , are said to work by activating the GLP-1 hormone, which might in turn reduce appetite and cravings and manage blood sugar level
If there is worsening glycemic control or failure to achieve targeted glycemic control, significant injection site reactions or allergic reactions, then other antidiabetic therapy should be considered